Crossject

Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections. Net sales break down by activity as follows:

• collaboration services on the methotrexate (70.6%);
• collaboration services on the treatment of macular edema (28.3%);
• other (1.1%).

All sales are in France.